GCNT2
protein-codingglucosaminyl (N-acetyl) transferase 2 (I blood group), the group of Glucosaminyl (N-acetyl) transferases/xylosyltransferases|Blood group antigens
Gene summary
This gene encodes the enzyme responsible for formation of the blood group I antigen. The i and I antigens are distinguished by linear and branched poly-N-acetyllactosaminoglycans, respectively. The encoded protein is the I-branching enzyme, a beta-1,6-N-acetylglucosaminyltransferase responsible for the conversion of fetal i antigen to adult I antigen in erythrocytes during embryonic development. Mutations in this gene have been associated with adult i blood group phenotype. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
- NACGT1
- II
- GCNT5
- CCAT
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~137.1 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0007289
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0007289
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0021548
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0007289
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0007289
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0007289
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Hematologic; Ophthalmologic
Intervention: Hematologic
Rationale: Variants associated with a blood group may be important in specific situations (eg, related to transfusion)
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to GCNT2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_145649.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 5 | 7 | |||
| missense | 4 | 4 | 24 | 6 | 38 | |
| nonsense | 1 | 2 | 1 | 4 | ||
| start loss | 0 | |||||
| frameshift | 2 | 2 | ||||
| splice donor/acceptor (+/-2bp) | 1 | 1 | ||||
| Total | 5 | 8 | 28 | 11 | 0 | 52 |
Highest pathogenic variant AF is 0.00016058072
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_663624.1 | 3 | MANE Select | |
| Ensembl | ENSP00000419411.2 | 3 | MANE Select | |
| RefSeq | NP_001361676.1 | 3 | Standard | |
| RefSeq | NP_001482.1 | 3 | MANE Plus Clinical |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Glycosphingolipid biosynthesis - lacto and neolacto series - Homo sapiens (human)
- Glycosphingolipid biosynthesis - neolactoseries
- terminal <i>O</i>-glycans residues modification
Biological Process
- glycosaminoglycan biosynthetic process
- protein glycosylation
- transforming growth factor beta receptor signaling pathway
- multicellular organism development
- positive regulation of cell population proliferation
Molecular Function
- N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity
Cellular Component
- Golgi membrane
- cellular_component
- Golgi apparatus
- membrane
- integral component of membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000379597
- Coding exons
- 3
- Length
- 137146
- Individuals with no LoFs
- 125589
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 159
- Defined
- 125748
- p
- 0.000632
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -1.10 | 262 | 216 | 1.21 | 0.0000120 | 2643 |
| Missense (PolyPhen) | 72 | 64.981 | 1.108 | 830 | ||
| Synonymous | -1.28 | 105 | 89.6 | 1.17 | 0.00000578 | 783 |
| Loss of Function | 1.14 | 9 | 13.5 | 0.665 | 6.53e-7 | 168 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.0017 | 0.0017 | notable |
| Latino/Admixed American | 0.00029 | 0.00029 | rare |
| Ashkenazi Jewish | 0.000099 | 0.000099 | rare |
| East Asian | 0.0026 | 0.0026 | notable |
| Finnish | 0.00028 | 0.00028 | rare |
| European (Non-Finnish) | 0.00025 | 0.00025 | rare |
| South Asian | 0.0010 | 0.0010 | notable |
| Other | 0.00098 | 0.00098 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Branching enzyme that converts linear into branched poly-N-acetyllactosaminoglycans. Introduces the blood group I antigen during embryonic development. It is closely associated with the development and maturation of erythroid cells. {ECO:0000269|PubMed:7579796, ECO:0000269|PubMed:8449405}.;
- Disease
- DISEASE: Cataract 13, with adult i phenotype (CTRCT13) [MIM:116700]: An opacification of the crystalline lens of the eye that frequently results in visual impairment or blindness. Opacities vary in morphology, are often confined to a portion of the lens, and may be static or progressive. In general, the more posteriorly located and dense an opacity, the greater the impact on visual function. CTRCT13 is associated with the rare adult i phenotype, in which adult red blood cells are rich in i antigen and contain low levels of I antigen. {ECO:0000269|PubMed:11739194}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.159
Intolerance Scores
- LoFtool
- 0.977
- RVIS EVS
- -1.3
- RVIS percentile EVS
- 4.95
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.414
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |